Research to cure
Key to the advancement of genomic medicineThe Clínica Universidad de Navarra has the Cima Universidad de Navarra, an applied medical research center, which allows us not only to develop diagnoses and treatments with the latest medical technology in the field of genomics, but also to carry out specific lines of research with the aim of continuing the advance of genomic medicine in the field of personalization of diagnosis, monitoring and treatment.
At Cima, our researchers collaborate closely with clinical specialists to deepen the knowledge of genetics and its application in Clinical Medicine.
We take advantage of the latest technology available to analyze the human genome and better understand how genetic factors influence health and disease.
What lines of research are we working on?
Gene therapy in monogenic diseases represents an important advance in the field of medicine, offering the possibility of treating hereditary genetic disorders by directly correcting the mutations responsible for the disease.
Cancer-related research is a dynamic, multidisciplinary field that ranges from understanding the underlying molecular mechanisms of the disease to developing new advanced therapies that offer hope to patients.
Identification of biomarkers of high-risk patients. Biomarkers are measurable biological indicators that provide information about an individual's health status, including his or her risk of developing certain diseases.
We count on CIMA LAB Diagnostics
Cima Lab Diagnostics brings together the three major laboratories for genetic and phenotypical analysis that belong to the Universidad de Navarra: the Clinical Genetics Unit and the molecular analysis unit of Pathological Anatomy of the Clinic, the Genetic Analysis Service of the Faculty of Sciences and the Cytometry laboratories of Cima and the Clínica Universidad de Navarra.
A network of eight hubs or genomic centers in Spain that has the capacity to sequence samples arriving from other hospitals.
Personalized Medicine Project
The Clínica Universidad de Navarra participates as a clinical center and as a genomic sequencing center for adult and pediatric patients in the Personalized Medicine Plan of the Carlos III Institute, whose objective is to facilitate access to personalized medicine for all oncopediatric patients regardless of their place of residence.